19-33302028-G-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_004364.5(CEBPA):​c.387C>A​(p.Pro129Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000761 in 1,182,176 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P129P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000029 ( 0 hom. )

Consequence

CEBPA
NM_004364.5 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.642

Publications

0 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 19-33302028-G-T is Benign according to our data. Variant chr19-33302028-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 706391.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.642 with no splicing effect.
BS2
High AC in GnomAd4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004364.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
NM_004364.5
MANE Select
c.387C>Ap.Pro129Pro
synonymous
Exon 1 of 1NP_004355.2
CEBPA
NM_001287424.2
c.492C>Ap.Pro164Pro
synonymous
Exon 1 of 1NP_001274353.1P49715-4
CEBPA
NM_001287435.2
c.345C>Ap.Pro115Pro
synonymous
Exon 1 of 1NP_001274364.1P49715-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
ENST00000498907.3
TSL:6 MANE Select
c.387C>Ap.Pro129Pro
synonymous
Exon 1 of 1ENSP00000427514.1P49715-1
CEBPA-DT
ENST00000718467.1
n.46+229G>T
intron
N/A
ENSG00000267727
ENST00000587312.1
TSL:3
n.*88G>T
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.0000403
AC:
6
AN:
148758
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000666
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000290
AC:
3
AN:
1033418
Hom.:
0
Cov.:
33
AF XY:
0.00000410
AC XY:
2
AN XY:
488366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
20680
American (AMR)
AF:
0.00
AC:
0
AN:
6566
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21330
South Asian (SAS)
AF:
0.00
AC:
0
AN:
20018
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
23842
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2618
European-Non Finnish (NFE)
AF:
0.00000338
AC:
3
AN:
887200
Other (OTH)
AF:
0.00
AC:
0
AN:
39518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000403
AC:
6
AN:
148758
Hom.:
0
Cov.:
32
AF XY:
0.0000690
AC XY:
5
AN XY:
72500
show subpopulations
African (AFR)
AF:
0.000122
AC:
5
AN:
41022
American (AMR)
AF:
0.0000666
AC:
1
AN:
15004
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3418
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5038
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9328
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66860
Other (OTH)
AF:
0.00
AC:
0
AN:
2048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Acute myeloid leukemia (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
6.9
DANN
Benign
0.92
PhyloP100
-0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060504477; hg19: chr19-33792934; API